August 20, 2009 - Oregon Fire District First to Use AutoPulse in Greater Portland Area

INVESTOR CONTACT:

A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
+1 (978) 421-9655

MEDIA CONTACT:

Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637
degan@zoll.com

SANDY, OREGON FIRE DISTRICT FIRST TO USE ZOLL AUTOPULSE IN GREATER PORTLAND AREA

Helps Save 52-Year-Old Construction Worker Stricken with SCA

August 20, 2009CHELMSFORD, Mass.—ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that the Sandy Fire District, in Sandy, Oregon, is the first emergency service in the Greater Portland area to install the AutoPulse® Non-invasive Cardiac Support Pump. The District credits the automatic chest compression device with helping to save the life of a 52-year-old contractor who went into sudden cardiac arrest (SCA).

According to Gary McLean, Sandy’s EMS Coordinator, doctors who treated Belus Schonek are calling him “The Miracle Man,” for having fully recovered from sudden cardiac arrest, the world’s leading cause of unexpected death. Typically, only about 5% to 10 % of victims survive out-of-hospital SCA. “Mr. Schonek was on the AutoPulse for about 45 minutes receiving chest compressions,” said McLean. “He was shocked eight times, but the medics could not convert him with a defibrillator. The AutoPulse, with its delivery of uninterrupted, high-quality chest compressions, substituted for his heart and kept the blood and oxygen circulating to his vital organs.”

“We could not have provided CPR for that long a period of time effectively without the AutoPulse. This device is changing the way we can work a cardiac arrest,” he added. “It also frees us to perform other life saving tasks.”

McLean went on to comment on how easy the device is to use, and stated that without the AutoPulse it would have been difficult for paramedics to perform effective CPR because Schonek had collapsed between a wall and the bed creating extremely tight quarters.

“They tell me I experienced an extremely rare medical recovery, especially for the length of time I was down. Forty-five minutes and no residual effects,” said Schonek, who had a stent implanted. “I have no history of heart disease and I’m grateful that my community had this device that helped keep me alive.”

As a result of Sandy Fire District’s experience with the AutoPulse, neighboring Estacada Fire Department recently became the second department in the Portland area to equip its rescue service with the AutoPulse.

The AutoPulseNon-invasive Cardiac Support Pump is an automated, portable device with an easy-to-use, load-distributing LifeBand® that squeezes the entire chest, improving blood flow to the heart and brain during sudden cardiac arrest (SCA). The AutoPulse may offer a significant advantage over manual CPR, moving blood more consistently than human providers. AutoPulse delivers high-quality, uninterrupted chest compressions to maintain myocardial and cerebral perfusion. Additionally, it offers the benefit of freeing up rescuers to focus on other life-saving interventions.

Over 4,200 AutoPulse devices are in use in hospital and emergency service organizations worldwide.

About Sudden Cardiac Arrest

SCA, an abrupt disruption of the heart’s function, which causes a lack of blood flow to vital organs, claims more than 325,000 lives each year in the U.S. It is the leading cause of unexpected death in the world and strikes without warning. Currently, only about 5 percent of victims survive; 95 percent will die from SCA.

About ZOLL Medical Corporation

ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation and temperature control therapies for the treatment of critical care patients. With products for pacing, defibrillation, circulation, temperature management, and fluid resuscitation, ZOLL provides a comprehensive set of technologies, including Real CPR Help® and See-Thru CPR®, which help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. During 2008 ZOLL marked the 25th anniversary of the Company’s resuscitation product development. For more information, visit www.zoll.com.

Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Quarterly Report on Form 10-Q filed with the SEC on August 7, 2009. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.

Copyright © 2009 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, AutoPulse, LifeBand, Real CPR Help, and See-Thru CPR are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.